CA-GLOBALLOGIC-INC.
11.1.2023 12:01:37 CET | Business Wire | Press release
GlobalLogic Inc., a Hitachi Group company and Digital Engineering leader, announced today that it has been named an overall Leader in the Zinnov Zones for ER&D Services 2022 Ratings. The report provides a 360-degree assessment of engineering research and development (ER&D) service providers, identifying their prowess and scalability across key markets and technologies. It is leveraged by company decision makers seeking to identify vetted service providers to support a wide range of engineering projects. Such resources are increasingly more important as investment in digital transformation rises rapidly across all industries to satisfy a growing demand for intelligent, connected, and data-driven experiences for consumers and company employees alike.
Zinnov is a global management consulting and strategy advisory firm with 20+ years of experience. As part of its annual ER&D Services Zinnov Zones ratings exercise, the company evaluates more than 50 global service providers across multiple verticals, micro-verticals, and geographies. GlobalLogic’s earned position as an overall leader indicates the digital engineering firm has demonstrated itself to be an Established, Expansive company when compared to its peers—labels specifically measuring:
- Established: proven specialization; R&D practice maturity (depth and maturity of services); innovation and IP; ecosystem linkages
- Expansive: scale and scalability; number of verticals serviced; client spread/diversification
Validating its overall leadership recognition, GlobalLogic was rated in the leadership zone for the following verticals and technologies:
- Automotive
- Consumer Software
- Data & AI Engineering
- Enterprise Software
- Experience Engineering
- Telecommunications
- Telehealth
The 2022 edition of the Zones ratings marks GlobalLogic’s seventh year earning a spot in the ER&D Services Ratings’ general leader quadrant, having first placed there in 2016. While GlobalLogic first moved to an overall leadership position three years ago, it has since moved up in its rating and earned higher leadership zone positions in several sub-categories listed above.
“The recognition received in the Zinnov Zones evaluation is a direct testament to the ingenuity, commitment, and skills displayed by our team members around the world,” said Arya Barirani, Chief Marketing Officer, GlobalLogic. “From our perspective, this rating acknowledges our continued ability to deepen our foothold in a wide variety of markets. It also acknowledges our dedication to broadening our experience in technologies that drive next- gen digital transformations. These investments in our people, training, and facilities are all designed to help us better serve our customers.”
Sidhant Rastogi, Managing Partner, Zinnov, said, “GlobalLogic’s intense focus on building new-age technology capabilities, combined with its digital accelerators and its self-contained innovation labs, has helped the firm drive high value transformation for its customers. GlobalLogic continues to strengthen its digital core through strategic acquisitions like Fortech, which has enabled it to expand its portfolio of offerings across technologies and geographies. A well-articulated growth strategy and a data-driven approach across its wide-spectrum of Digital Engineering Services offerings has helped GlobalLogic firmly anchor its leadership position in the 2022 Zinnov Zones ER&D ratings.”
The 2022 ER&D Services Ratings report as well as prior year reports can be found here: https://zinnovzones.com/ratings/e-r-and-d-services/overall/2022.
About Zinnov
Founded in 2002, Zinnov is a global management consulting and strategy advisory firm with a presence in New York, Santa Clara, Seattle, Houston, Bangalore, Gurgaon, Paris, and Pune. With a team of experienced consultants, subject matter experts, and research professionals, Zinnov has partnered with Global Enterprises, Fortune 2000 companies, Global System Integrators, and Private Equity firms across their value creation journeys to develop actionable insights – across revenue, talent, innovation, scale, and optimization. For more information, visit Zinnov.
About GlobalLogic
GlobalLogic (www.globallogic.com) is a leader in digital engineering. We help brands across the globe design and build innovative products, platforms, and digital experiences for the modern world. By integrating experience design, complex engineering, and data expertise – we help our clients imagine what’s possible and accelerate their transition into tomorrow’s digital businesses. Headquartered in Silicon Valley, GlobalLogic operates design studios and engineering centers around the world, extending our deep expertise to customers in the automotive, communications, financial services, healthcare and life sciences, manufacturing, media and entertainment, semiconductor, and technology industries. GlobalLogic is a Hitachi Group Company operating under Hitachi, Ltd. (TSE: 6501), which contributes to a sustainable society with a higher quality of life by driving innovation through data and technology as the Social Innovation Business.
GlobalLogic is a trademark of GlobalLogic. All other brands, products or service names are or may be trademarks or service marks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230111005241/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom